Bioharvest Sciences BHST
NASDAQ BHST
$1.67 -0.01 (-0.48%)
As of: Oct 21, 2026 · 3:28 PM EDT

Bioharvest Sciences (BHST) Short term Debt (2023 - 2024)

Updated

Bioharvest Sciences (BHST) recorded Short term Debt of $1.19 million in the quarter ended Sep 30, 2024, up 2.5% from the prior quarter.

Analysis

Bioharvest Sciences (BHST) Short term Debt (2023 - 2024) Analysis & Trends

As of Dec 31, 2023, Bioharvest Sciences reported Short term Debt of $20.53 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Bioharvest Sciences 30.78 Mn -37.59 Mn 5.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.19 Mn
Jun 30, 2024 1.16 Mn
Dec 31, 2023 20.53 Mn
API Access

Bioharvest Sciences Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BHST&period=max&api_key=YOUR_API_KEY